Position in ACIU
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$245,444
-$50,797 QoQ
Shares Held
89,253
-5.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 20.474381813496464.ToString("F0")%
Shared 0.ToString("F0")%
None 79.52561818650354.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ACIU ranks #321 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ACIU
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $245,444 | 89,253 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $296,241 | 94,345 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $265,973 | 92,033 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $147,974 | 72,895 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $134,645 | 72,004 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $449,696 | 166,555 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $245,476 | 64,941 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $313,879 | 78,667 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,096,206 | 1,383,854 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $8,786,200 | 1,757,240 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $4,963,778 | 1,741,677 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,195,010 | 1,758,041 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,564,455 | 1,950,622 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,979,268 | 1,950,622 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,248,430 | 1,977,352 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,108,753 | 1,969,184 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $8,017,888 | 2,004,472 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,105,145 | 2,243,464 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,728,767 | 555,703 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,124,723 | 267,935 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $630,160 | 82,807 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $818,022 | 158,225 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $705,437 | 144,557 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $513,209 | 76,257 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $492,282 | 71,242 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||